Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma
Clinical trial NCT02611700 · UNKNOWN
Trial details
- NCT number
- NCT02611700
- Sponsor
- Biotech Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2018-12-01
- Enrollment
- 504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.